期刊文献+

膀胱癌患者外周血淋巴细胞染色体畸变研究 被引量:4

Study on Chromosome Aberration of Lymphocytes in Peripheral Blood of Patients With Bladder Carcinoma
下载PDF
导出
摘要 背景与目的:探讨膀胱癌患者外周血淋巴细胞染色体数目畸变与临床分期、病理分级及预后的关系。材料与方法:对30例膀胱癌患者行外周血淋巴细胞染色体数目畸变分析。结果:患者组中亚二倍体、超二倍体、多倍体的出现率明显增高,总畸变率明显高于正常对照组(P<0.05),且随着临床分期及病理分级的增加,染色体的二倍体率下降。结论:随着肿瘤恶性程度的增加,染色体变异范围扩大,多倍体的出现可能预示着肿瘤的恶性倾向和患者的预后不佳。 BACKGROUND AND AIM: To investigate the relationship between chromosome numerical aberration of lymphocytes in peripheral blood and clinical stage , pathological grading and prognosis in patients with bladder carcinoma. MATERIALS AND METHODS: Cytogenetic studies were taken on 30 bladder carcinoma by examining their chromosome numerical aberration of lymphocytes in peripheral blood. RESULTS: The frequencies of hypodiploid, hyperdiploid and polyloid were significantly increased.The general abnormality rate was significantly higher than the normal control group (P 〈 0. 05 ) . As the clinical staging and pathological grading became more advanced, the diploid rate was reduced. CONCLUSION: With higher malignant degree of bladder carcinoma, the range of chromosome numerical aberration increased. This indicated that the appearance of polyloidy was closely correlated with the malignant level of the carcinoma and unfavourable prognosis.
出处 《癌变.畸变.突变》 CAS CSCD 2008年第2期160-162,共3页 Carcinogenesis,Teratogenesis & Mutagenesis
关键词 膀胱肿瘤 淋巴细胞 染色体畸变 bladder neoplasms carcinoma lymphocytes chromosome aberration
  • 相关文献

参考文献8

二级参考文献32

  • 1张中寿,癌症,1993年,12卷,23页
  • 2刘中贤,遗传与疾病,1991年,8卷,14页
  • 3刘运初,中华实验外科杂志,1988年,5卷,5页
  • 4吴明明,中华泌尿外科杂志,1985年,6卷,70页
  • 5Zhou Xingting,Hum Genet,1984年,67卷,249页
  • 6Bartlett JMS, Adie L, Watters AD, et al. Chromosome aberrations in transitional cell carcinoma that predictive of disease outcome are independent of polyploidy. BJU International, 1999 ,84: 775 - 779.
  • 7Bartlett JMS, Watters AD, Ballantyne SA, et al. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?. Br J Cancer, 1998,77(12) :2193 - 2198.
  • 8Edwards J, Duncan P, Going JJ, et al. Identification of loci associated with putative recurrence gene in transitional cell carcinoma of the urinary bladder. J Pathol, 2002,196: 380 - 385.
  • 9Miyao N, Tsai YC, Lerner SP, et al. Role of chromosome 9 in human bladder cancer. Cancer Res, 1993,53:4066- 4070.
  • 10SauterG,MochH,CarrollP,et al. Chromosome-9 loss detected by Fluorescence In Situ Hybridization in bladder cancer. Int J Cancer, 1995,64:99- 103.

共引文献20

同被引文献33

  • 1Guo-Zhong Ji,Xue-Hao Wang,Lin Miao,Zheng Liu,Ping Zhang,Fa-Ming Zhang,Jian-Bing Yang.Role of transforming growth factor-betal-smad signal transduction pathway in patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(4):644-648. 被引量:26
  • 2URISTMJ, DICOMOCJ, LU M L, et al. Loss of p63 expression is associated with tumor progression in bladder cancer[J].Am J Pathol,2002,161:1199-1206.
  • 3PARK BJ, LEE SJ, LEE KSJ, et al. Frequent alteration of p63 expression in human primary bladder carcinomas[J].Cancer Res, 2000,60:3370 - 3374.
  • 4MATSUMOTO H, WADA T, FUKUNAGA K, et al. Bax to Bcl- 2 ratio and Ki 67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer[J].Jpn J Clin Oncol, 2004,34(3):124-130.
  • 5BOZLU M, ORHAN D,BALTACI S, et al. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder[J]. Int Urol Nephrol,2002,33(1) :59-66.
  • 6MARGULIS V, SHARIAT S F, ASHFAQ R, et al. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ confined disease[J]. Cancer Res, 2006,12(24) : 7369-7373.
  • 7YANG A, MCKEON F. p63 and p73: p53 mimics, menaces and more[J]. Nat Rev Mol Cell Biol, 2000,1:19-207.
  • 8Tilki D, Irmak S, Oliveira-Ferrer L, et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer [ J ]. Oncogene, 2006,25 (36) : 4965 -4974.
  • 9Lee J, Kim H K, Rho J Y, et al. The human OCT-4 isoforms differ in their ability to confer self-renewal [J]. J Biol Chem, 2006,281 (44) : 33554-33565.
  • 10Hansis C. Totipotency, cell differentiation and reprogramming in humans [J]. Reprod Biomed Online, 2006, 13(4) :551-557.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部